Expert-Led Discourse on Treatment Strategies for Advanced HER2-Negative Gastric/GEJ Cancers

Learn strategies for incorporating immunotherapies and new molecularly targeted agents into the care of patients with advanced HER2-negative gastric/GEJ cancers with expert slides from a live webinar.

Share

Program Content

Activities

Therapy for Untreated HER2-Negative Advanced Gastric/GEJ Cancers
Initial Therapy for Previously Untreated Advanced HER2-Negative Gastric/GEJ Cancers
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 21, 2022

Expires: July 20, 2023

Previously Treated Advanced HER2-Negative Gastric/GEJ Cancers
Therapy for Previously Treated Advanced HER2-Negative Gastric/GEJ Cancers
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 21, 2022

Expires: July 20, 2023

Faculty

cover img faculity

Yelena Y. Janjigian, MD

Associate Attending Physician
Chief, 
Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medical College
New York, New York

cover img faculity

Samuel Klempner, MD

Associate Professor
Department of Medicine, Division of Hematology-Oncology
Mass General Cancer Center, Harvard Medical Center
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by an educational grant

Astellas Pharma US